Page last updated: 2024-08-18

pyrroles and Atrial Fibrillation

pyrroles has been researched along with Atrial Fibrillation in 47 studies

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.13)18.7374
1990's0 (0.00)18.2507
2000's15 (31.91)29.6817
2010's31 (65.96)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calkins, H; Piccini, JP1
Brodowski, K; Jaworski, K; Kosior, DA; Krzykwa, A; Opolski, G; Zylińska, E1
Abaci, O; Coskun, U; Kilickesmez, KO; Kocas, C; Oktay, V; Yigit, Z; Yildiz, A; Yildiz, CE1
Lappegård, KT; Pop, G; Pop-Purceleanu, M; Sexton, J; Tendolkar, I; van Heerde, W1
Guo, F; Han, W; Li, JX; Li, YD; Tang, BP; Tang, Q; Zhang, YY1
Liu, X; Qu, Y; Shen, H; Xia, J1
Li, Y; Qi, X; Yang, Q1
Guan, Y; Guo, HY; Shan, ZL; Wang, YT; Yuan, HT; Zhang, Y1
Gu, HY; Jiang, L; Shi, MY; Teng, SC; Xue, FH; Yin, F; Zhu, J1
Crijns, HJ; De Boer, HC; De Jong, AM; Kamphuisen, PW; Kuiper, M; Lau, DH; Linz, D; Lumeij, S; Maass, AH; Rienstra, M; Schotten, U; Spronk, HM; Ten Cate, H; Van Gelder, IC; van Hunnik, A; van Zonneveld, AJ; Verheule, S; Zeemering, S1
Chiang, FT; Hwang, JJ; Lai, LP; Lin, JL; Tsai, CT; Wang, YC1
Kim, JH; Kim, JS; Kim, WS; Lee, SH; Lee, YT; On, YK; Shin, DH; Song, YB; Sung, J1
Almroth, H; Boman, K; Englund, A; Höglund, N; Jensen, S; Kjellman, B; Rosenqvist, M; Tornvall, P1
Kanic, V; Naji, F; Sabovic, M; Suran, D; Vokac, D1
Cai, J; Chi, L; Feng, J; Ji, Q; Mei, Y; Sun, Y; Wang, X; Xie, S1
Cai, JZ; Feng, J; Ji, Q; Mei, YQ; Sun, YF; Wang, XS; Xie, SL; Zhou, YX1
Aronow, WS; Banach, M; Bielecka-Dabrowa, A; Desai, R; Goch, JH; Maciejewski, M; Rysz, J1
Arai, H; Ito, F; Miyagi, N; Someya, T; Tamura, K; Ushiyama, T1
Abuladze, GV; Dundua, GI; Dzhindzholiia, NR; Nebieridze, MI1
Camm, J; Hosseini, MT; Jahangiri, M; Kourliouros, A; Mayr, M; Sarsam, M; Valencia, O1
Bentz, K; Eick, C; Kettering, K; Laszlo, R; Menzel, KA; Schreieck, J; Schreiner, B1
Takagi, H; Umemoto, T1
Bloom, HL; Dudley, SC; Jones, DP; Negi, S; Shukrullah, I; Veledar, E1
Kuo, CD1
Almroth, H; Andersson, J; Boman, K; Englund, A; Höglund, N; Jensen, S; Rosenqvist, M; Tornvall, P1
Bouwels, L; de Leeuw, FE; Enajat, M; Pop, G; Pop-Purceleanu, M; Tendolkar, I; van Kuilenburg, J; van Wingen, G; Zwiers, MP1
Cai, J; Chi, L; Feng, J; Ji, Q; Mei, Y; Sun, Y; Wang, X1
Chaitman, BR; Goldberger, JJ; Messig, M; Schwartz, GG1
Akilli, H; Alihanoglu, Y; Altunkeser, BB; Aribas, A; Ayhan, S; Can, I; Demir, K; Koc, F; Vatankulu, MA1
Asirvatham, SJ; Bradley, D; Brady, PA; Cha, YM; Friedman, PA; Herges, R; Hodge, D; Koestler, C; Lerman, A; Lopez-Jimenez, F; Munger, TM; Packer, DL; Suleiman, M1
Goette, A1
Komatsu, T; Kunugita, F; Nakamura, M; Ozawa, M; Sato, Y; Tachibana, H1
Bidhendi, LM; Bina, P; Fathollahi, MS; Karimi, A; Molai, M; Rezvanfard, M; Sadeghian, S; Yousefi, A; Zare, E1
Fenech, ME; Mackay, JW; Myint, KS1
Almroth, H; Andersson, J; Boman, K; Englund, A; Höglund, N; Jensen, SM; Rosenqvist, M; Tornvall, P1
Creswell, LL1
Bang, CN; Gislason, GH; Greve, AM; Køber, L; Torp-Pedersen, C; Wachtell, K1
Dernellis, J; Panaretou, M1
Altinbas, A; Aslan, SM; Dogan, A; Kucuktepe, Z; Ozaydin, M; Ozturk, M; Varol, E1
Candura, D; Chello, M; Covino, E; D'Ambrosio, A; Di Sciascio, G; Pasceri, V; Patti, G1
García-Fernández, A; Mainar, L; Marín, F; Martínez, JG; Roldán, V1
Hawkins, NM; MacDonald, MR; Padfield, GJ1
Orlandi, QG; Shroff, GR1
Brozmanova, K; Mardiak, J; Mego, M; Obertova, J; Reckova, M; Sycova-Mila, Z1
Blazing, M; Cannon, CP; Gersh, B; McLean, DS; Ravid, S; Shui, A1
Camm, J; De Souza, A; Jahangiri, M; Kourliouros, A; Marciniak, A; Roberts, N; Tsiouris, A; Valencia, O1
Johnson, RW; Keenan, TH; Kosh, JW; Sowell, JW1

Reviews

2 review(s) available for pyrroles and Atrial Fibrillation

ArticleYear
The preventive effect of atorvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials.
    BMC cardiovascular disorders, 2014, Aug-13, Volume: 14

    Topics: Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Chi-Square Distribution; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Odds Ratio; Primary Prevention; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Secondary Prevention; Treatment Outcome

2014
Effect of Atorvastatin on Serum Levels of Total Cholesterol and High-Sensitivity C-reactive Protein in High-Risk Patients with Atrial Fibrillation in Asia.
    Clinical therapeutics, 2015, Volume: 37, Issue:8

    Topics: Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Cholesterol; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Treatment Outcome

2015

Trials

20 trial(s) available for pyrroles and Atrial Fibrillation

ArticleYear
Patients with stable coronary artery disease receiving chronic statin treatment who are undergoing noncardiac emergency surgery benefit from acute atorvastatin reload.
    Cardiology, 2014, Volume: 128, Issue:3

    Topics: Aged; Atorvastatin; Atrial Fibrillation; Coronary Artery Disease; Death, Sudden, Cardiac; Disease-Free Survival; Double-Blind Method; Emergency Treatment; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Myocardial Infarction; Postoperative Complications; Preoperative Care; Prospective Studies; Pyrroles; Treatment Outcome

2014
Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial.
    American heart journal, 2008, Volume: 156, Issue:1

    Topics: Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; Bradycardia; Cardiac Pacing, Artificial; Combined Modality Therapy; Confidence Intervals; Echocardiography, Doppler; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Pacemaker, Artificial; Probability; Proportional Hazards Models; Prospective Studies; Pyrroles; Reference Values; Risk Assessment; Survival Analysis; Treatment Outcome

2008
The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery.
    American heart journal, 2008, Volume: 156, Issue:2

    Topics: Aged; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Coronary Artery Bypass, Off-Pump; Elective Surgical Procedures; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Peptide Fragments; Postoperative Complications; Premedication; Prospective Studies; Pyrroles

2008
Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study.
    European heart journal, 2009, Volume: 30, Issue:7

    Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Double-Blind Method; Electric Countershock; Female; Heptanoic Acids; Humans; Male; Prospective Studies; Pyrroles; Secondary Prevention; Sweden; Treatment Outcome

2009
Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting.
    Circulation journal : official journal of the Japanese Circulation Society, 2009, Volume: 73, Issue:12

    Topics: Administration, Oral; Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass, Off-Pump; Double-Blind Method; Drug Administration Schedule; Elective Surgical Procedures; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Preoperative Care; Pyrroles; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

2009
[Effect of atorvastatin on postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting].
    Zhonghua yi xue za zhi, 2009, Nov-17, Volume: 89, Issue:42

    Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Coronary Artery Bypass; Coronary Artery Disease; Female; Heptanoic Acids; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pyrroles; Risk Factors

2009
Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study.
    Lipids in health and disease, 2010, Feb-23, Volume: 9

    Topics: Adult; Aged; Atorvastatin; Atrial Fibrillation; Body Mass Index; Cardiomyopathy, Dilated; Echocardiography; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-10; Interleukin-6; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Prospective Studies; Pyrroles; Tumor Necrosis Factor-alpha

2010
Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial.
    The Journal of thoracic and cardiovascular surgery, 2011, Volume: 141, Issue:1

    Topics: Aged; Atorvastatin; Atrial Fibrillation; Chi-Square Distribution; Coronary Artery Bypass; Drug Administration Schedule; Female; Heart Valve Prosthesis Implantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; London; Male; Middle Aged; Preoperative Care; Prospective Studies; Pyrroles; Regression Analysis; Risk Assessment; Risk Factors; Single-Blind Method; Time Factors; Treatment Outcome

2011
Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial).
    Journal of cardiovascular electrophysiology, 2011, Volume: 22, Issue:4

    Topics: Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; Double-Blind Method; Electric Countershock; Female; Follow-Up Studies; Heptanoic Acids; Humans; Inflammation Mediators; Male; Middle Aged; Oxidative Stress; Pyrroles; Treatment Outcome

2011
Markers of fibrinolysis as predictors for maintenance of sinus rhythm after electrical cardioversion.
    Thrombosis research, 2011, Volume: 127, Issue:3

    Topics: Aged; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Electric Countershock; Female; Fibrinolysis; Heptanoic Acids; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pyrroles; Recurrence; Tissue Plasminogen Activator

2011
One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial.
    International journal of geriatric psychiatry, 2012, Volume: 27, Issue:1

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; Atrophy; Azetidines; Biomarkers; Cholesterol; Double-Blind Method; Ezetimibe; Female; Heptanoic Acids; Humans; Male; Memory; Memory Disorders; Neuropsychological Tests; Pyrroles; Temporal Lobe

2012
Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting.
    International heart journal, 2011, Volume: 52, Issue:1

    Topics: Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Postoperative Period; Preoperative Period; Pyrroles; Treatment Outcome

2011
High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    American heart journal, 2011, Volume: 161, Issue:5

    Topics: Atorvastatin; Atrial Fibrillation; Cholesterol; Chronic Disease; Disease Progression; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Pyrroles; Retrospective Studies; Stroke; Survival Rate; Time Factors; Treatment Outcome

2011
Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2011, Volume: 20, Issue:5

    Topics: Analysis of Variance; Anti-Arrhythmia Agents; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Chronic Disease; Electric Countershock; Female; Fibrinogen; Health Status Indicators; Heptanoic Acids; Humans; Leukocyte Count; Male; Middle Aged; Pyrroles; Secondary Prevention; Time Factors; Warfarin

2011
Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial.
    Heart rhythm, 2012, Volume: 9, Issue:2

    Topics: Aged; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Catheter Ablation; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Postoperative Complications; Pulmonary Veins; Pyrroles; Quality of Life; Secondary Prevention; Treatment Outcome

2012
The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin.
    International journal of cardiology, 2013, Sep-01, Volume: 167, Issue:5

    Topics: Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Double-Blind Method; Electric Countershock; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrroles; Recurrence; Treatment Outcome

2013
Effect of C-reactive protein reduction on paroxysmal atrial fibrillation.
    American heart journal, 2005, Volume: 150, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Female; Heptanoic Acids; Humans; Male; Middle Aged; Pyrroles

2005
Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion.
    The American journal of cardiology, 2006, May-15, Volume: 97, Issue:10

    Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Body Mass Index; C-Reactive Protein; Electric Countershock; Female; Heptanoic Acids; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyrroles; Recurrence; Risk Factors; Treatment Outcome

2006
Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.
    Circulation, 2006, Oct-03, Volume: 114, Issue:14

    Topics: Aged; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Cardiac Surgical Procedures; Cerebrovascular Disorders; Female; Heart Diseases; Heptanoic Acids; Humans; Length of Stay; Male; Middle Aged; Postoperative Complications; Pyrroles

2006
Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials.
    American heart journal, 2008, Volume: 155, Issue:2

    Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Atorvastatin; Atrial Fibrillation; Dose-Response Relationship, Drug; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Pravastatin; Pyrroles; Thrombolytic Therapy; Tirofiban; Tyrosine

2008

Other Studies

25 other study(ies) available for pyrroles and Atrial Fibrillation

ArticleYear
Catheter ablation of rotational activity in atrial fibrillation: A barren oasis?
    American heart journal, 2018, Volume: 205

    Topics: Atrial Fibrillation; Catheter Ablation; Follow-Up Studies; Heart Atria; Humans; Pyrroles; Vinyl Compounds

2018
[Role of inflammation in etiology of atrial fibrillation--is lone arrhythmia really alone].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:4

    Topics: Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Pyrroles; Recurrence

2012
Comparison of rosuvastatin versus atorvastatin for preventing postoperative atrial fibrillation.
    The heart surgery forum, 2013, Volume: 16, Issue:3

    Topics: Atorvastatin; Atrial Fibrillation; Comorbidity; Coronary Artery Bypass; Coronary Artery Disease; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Premedication; Prevalence; Pyrimidines; Pyrroles; Retrospective Studies; Risk Assessment; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Turkey

2013
Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy.
    Journal of neuroinflammation, 2013, Jun-28, Volume: 10

    Topics: Aged; Amygdala; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Azetidines; Brain; Cognition; Electrocardiography; Executive Function; Ezetimibe; Female; Heptanoic Acids; Hippocampus; Humans; Image Processing, Computer-Assisted; Inflammation; Magnetic Resonance Imaging; Male; Memory; Neuroimaging; Neuropsychological Tests; Psychomotor Performance; Pyrroles; Reaction Time; Vocabulary

2013
Effect of atorvastatin on left atrial function of patients with paroxysmal atrial fibrillation.
    Genetics and molecular research : GMR, 2013, Sep-10, Volume: 12, Issue:3

    Topics: Adult; Atorvastatin; Atrial Fibrillation; Atrial Function, Left; Echocardiography; Female; Heart Atria; Heptanoic Acids; Humans; Hypertension; Male; Middle Aged; Pyrroles

2013
Role of inflammation in the initiation and maintenance of atrial fibrillation and the protective effect of atorvastatin in a goat model of aseptic pericarditis.
    Molecular medicine reports, 2015, Volume: 11, Issue:4

    Topics: Animals; Atorvastatin; Atrial Fibrillation; Cardiac Surgical Procedures; Cytokines; Disease Models, Animal; Goats; Heart Atria; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Male; Pericarditis; Pyrroles

2015
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
    European heart journal, 2017, 01-01, Volume: 38, Issue:1

    Topics: Analysis of Variance; Animals; Antithrombins; Atrial Fibrillation; Cell Proliferation; Dabigatran; Female; Fibrinolytic Agents; Fibroblasts; Fibrosis; Goats; Heart Atria; Indazoles; Mice, Transgenic; Nadroparin; Peptide Hydrolases; Pyrroles; Quinazolines; Rats; Receptors, Thrombin; Thrombin; Thrombophilia; Urea

2017
Comparison of atorvastatin and simvastatin in prevention of atrial fibrillation after successful cardioversion.
    International heart journal, 2009, Volume: 50, Issue:2

    Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Male; Middle Aged; Odds Ratio; Pyrroles; Retrospective Studies; Simvastatin; Treatment Outcome

2009
Pravastatin treatment before coronary artery bypass grafting for reduction of postoperative atrial fibrillation.
    General thoracic and cardiovascular surgery, 2010, Volume: 58, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass; Disease-Free Survival; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Pravastatin; Proportional Hazards Models; Pyrroles; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

2010
[The efficasy of atorvastatin in the case of paroxismal atrial fibrillation in patients with ischemic heart disease].
    Georgian medical news, 2010, Issue:180

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Pyrroles; Treatment Outcome

2010
Atorvastatin treatment affects atrial ion currents and their tachycardia-induced remodeling in rabbits.
    Life sciences, 2010, Oct-09, Volume: 87, Issue:15-16

    Topics: Animals; Atorvastatin; Atrial Fibrillation; Female; Heart Atria; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Ion Channels; Oxidative Stress; Patch-Clamp Techniques; Pyrroles; Rabbits; Tachycardia; Time Factors

2010
Effect of preoperative statin therapy on postoperative atrial fibrillation in cardiac surgery.
    Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:12

    Topics: Administration, Oral; Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass, Off-Pump; Double-Blind Method; Drug Administration Schedule; Elective Surgical Procedures; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Preoperative Care; Pyrroles; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

2010
Statins, inflammation, oxidative stress, and atrial fibrillation.
    Journal of cardiovascular electrophysiology, 2011, Volume: 22, Issue:4

    Topics: Atorvastatin; Atrial Fibrillation; Female; Heptanoic Acids; Humans; Male; Pyrroles

2011
Neutral effects of statins to prevent atrial fibrillation recurrences after catheter ablation of atrial fibrillation: should we bury upstream therapy for secondary prevention of atrial fibrillation?
    Heart rhythm, 2012, Volume: 9, Issue:2

    Topics: Atorvastatin; Atrial Fibrillation; Catheter Ablation; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Postoperative Complications; Pulmonary Veins; Pyrroles

2012
Long-term efficacy of upstream therapy with lipophilic or hydrophilic statins on antiarrhythmic drugs in patients with paroxysmal atrial fibrillation: comparison between atorvastatin and pravastatin.
    International heart journal, 2011, Volume: 52, Issue:6

    Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pravastatin; Pyrroles; Retrospective Studies; Secondary Prevention; Tachycardia, Paroxysmal; Time Factors; Treatment Outcome

2011
The effect of a high dose of atorvastatin on the occurrence of atrial fibrillation after coronary artery bypass grafting.
    The Annals of thoracic surgery, 2012, Volume: 94, Issue:1

    Topics: Aged; Atorvastatin; Atrial Fibrillation; Coronary Artery Bypass; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Male; Middle Aged; Postoperative Complications; Pyrroles; Retrospective Studies

2012
Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin.
    British journal of hospital medicine (London, England : 2005), 2012, Volume: 73, Issue:2

    Topics: Acute Disease; Aged; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; Drug Interactions; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Pyrroles; Rhabdomyolysis; Warfarin

2012
Invited commentary.
    The Annals of thoracic surgery, 2012, Volume: 94, Issue:1

    Topics: Atorvastatin; Atrial Fibrillation; Coronary Artery Bypass; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Postoperative Complications; Pyrroles

2012
Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.
    European journal of preventive cardiology, 2014, Volume: 21, Issue:3

    Topics: Age Factors; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; Chi-Square Distribution; Comorbidity; Denmark; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Polypharmacy; Pravastatin; Propensity Score; Proportional Hazards Models; Pyrroles; Registries; Retrospective Studies; Risk Factors; Sex Factors; Simvastatin; Time Factors; Treatment Outcome

2014
Effect of statins on preventing recurrence of atrial fibrillation after electrical cardioversion.
    The American journal of cardiology, 2006, Nov-01, Volume: 98, Issue:9

    Topics: Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Combined Modality Therapy; Electric Countershock; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Secondary Prevention

2006
Letter by Padfield et al regarding article, "Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After Ca
    Circulation, 2007, Apr-17, Volume: 115, Issue:15

    Topics: Atorvastatin; Atrial Fibrillation; Cardiac Surgical Procedures; Confounding Factors, Epidemiologic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications; Pyrroles; Randomized Controlled Trials as Topic; Research Design

2007
Letter by Shroff and Orlandi regarding article, "Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia Afte
    Circulation, 2007, Apr-17, Volume: 115, Issue:15

    Topics: Atorvastatin; Atrial Fibrillation; Cardiac Surgical Procedures; Confounding Factors, Epidemiologic; Coronary Artery Bypass; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications; Pyrroles; Randomized Controlled Trials as Topic; Research Design

2007
Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:11

    Topics: Aged; Atrial Fibrillation; Benzenesulfonates; Carcinoma, Renal Cell; Cardiovascular Diseases; Chest Pain; Drug Interactions; Follow-Up Studies; Humans; Indoles; Kidney Neoplasms; Middle Aged; Myocardial Ischemia; Neoplasm Invasiveness; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Risk Assessment; Sampling Studies; Severity of Illness Index; Sorafenib; Sunitinib

2007
Dose-related effect of statins on atrial fibrillation after cardiac surgery.
    The Annals of thoracic surgery, 2008, Volume: 85, Issue:5

    Topics: Aged; Aged, 80 and over; Aortic Valve; Atorvastatin; Atrial Fibrillation; Cohort Studies; Coronary Artery Bypass; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Heart Valve Prosthesis Implantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Postoperative Complications; Pyrroles; Retrospective Studies; Risk Factors; Simvastatin; Treatment Outcome

2008
Synthesis of substituted 2-aminopyrrole analogs of lidocaine II.
    Journal of pharmaceutical sciences, 1979, Volume: 68, Issue:8

    Topics: Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Chemical Phenomena; Chemistry; Guinea Pigs; Lidocaine; Male; Mice; Pyrroles; Structure-Activity Relationship

1979